Literature DB >> 29643753

Reefer to the Rescue: The Dope on Cannabidiol as a Multi-Symptom Panacea for Dravet Syndrome.

Akshay Gupta, Viji Santhakumar.   

Abstract

Year:  2018        PMID: 29643753      PMCID: PMC5887613          DOI: 10.5698/1535-7597.18.2.118

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN: 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  11 in total

Review 1.  Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.

Authors:  Orrin Devinsky; Maria Roberta Cilio; Helen Cross; Javier Fernandez-Ruiz; Jacqueline French; Charlotte Hill; Russell Katz; Vincenzo Di Marzo; Didier Jutras-Aswad; William George Notcutt; Jose Martinez-Orgado; Philip J Robson; Brian G Rohrback; Elizabeth Thiele; Benjamin Whalley; Daniel Friedman
Journal:  Epilepsia       Date:  2014-05-22       Impact factor: 5.864

2.  Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.

Authors:  Orrin Devinsky; J Helen Cross; Linda Laux; Eric Marsh; Ian Miller; Rima Nabbout; Ingrid E Scheffer; Elizabeth A Thiele; Stephen Wright
Journal:  N Engl J Med       Date:  2017-05-25       Impact factor: 91.245

Review 3.  From genotype to phenotype in Dravet disease.

Authors:  Svetlana Gataullina; Olivier Dulac
Journal:  Seizure       Date:  2016-10-21       Impact factor: 3.184

4.  A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity.

Authors:  Katrina Hurst; Corinne Badgley; Tanner Ellsworth; Spencer Bell; Lindsey Friend; Brad Prince; Jacob Welch; Zack Cowan; Ryan Williamson; Chris Lyon; Brandon Anderson; Brian Poole; Michael Christensen; Michael McNeil; Jarrod Call; Jeffrey G Edwards
Journal:  Hippocampus       Date:  2017-06-27       Impact factor: 3.899

5.  Dissecting the phenotypes of Dravet syndrome by gene deletion.

Authors:  Moran Rubinstein; Sung Han; Chao Tai; Ruth E Westenbroek; Avery Hunker; Todd Scheuer; William A Catterall
Journal:  Brain       Date:  2015-05-27       Impact factor: 13.501

Review 6.  Cannabis and Endocannabinoid Signaling in Epilepsy.

Authors:  István Katona
Journal:  Handb Exp Pharmacol       Date:  2015

7.  Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol.

Authors:  Reesha R Patel; Cindy Barbosa; Tatiana Brustovetsky; Nickolay Brustovetsky; Theodore R Cummins
Journal:  Brain       Date:  2016-06-05       Impact factor: 13.501

8.  Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome.

Authors:  Joshua S Kaplan; Nephi Stella; William A Catterall; Ruth E Westenbroek
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-02       Impact factor: 11.205

9.  Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses.

Authors:  Sergiy Sylantyev; Thomas P Jensen; Ruth A Ross; Dmitri A Rusakov
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-07       Impact factor: 11.205

Review 10.  An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors.

Authors:  Paula Morales; Patricia H Reggio
Journal:  Cannabis Cannabinoid Res       Date:  2017-10-01
View more
  1 in total

1.  Synthetic and Natural Derivatives of Cannabidiol.

Authors:  Paula Morales; Nadine Jagerovic
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.